For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250515:nRSO8971Ia&default-theme=true
RNS Number : 8971I Iconic Labs PLC 15 May 2025
15 May 2025
Iconic Labs Plc
("Iconic" or the "Company")
Result of AGM
Iconic Labs Plc (LSE:ICON) is pleased to announce that at the Annual General
Meeting ("AGM") held earlier today, Resolutions 1 to 9 were all were duly
approved by shareholders by way of a poll.
The results of the poll were as follows:
Resolutions For % Against % Withheld
1 To receive and adopt the accounts for the financial year ended 30 June 2024. 3,704,201 99.96% 1,303 0.04% 1,561
2 To re-appoint RPG Chartered Accountants as Auditors. 3,702,067 99.91% 3,437 0.09% 1,561
3 To authorise the Directors to determine the remuneration of the Auditors. 3,703,158 99.95% 1,799 0.05% 2,108
4 To re-appoint John Farquharson as a Director. 3,687,130 99.53% 17,487 0.47% 2,448
5 To re-appoint Bela Lendvai-Lintner as a Director. 3,697,050 99.80% 7,567 0.20% 2,448
6 To re-appoint Victor Humberdot as a Director. 3,698,465 99.83% 6,152 0.17% 2,448
7 To authorise the Directors to allot shares up to a maximum aggregate nominal 3,698,431 99.82% 6,663 0.18% 1,971
amount of £2,985,223.22.
Special Resolutions:
8 To empower the Directors to generally allot relevant equity securities. 3,698,666 99.83% 6,428 0.17% 1,971
9 To authorise the Directors to make market purchases of own shares. 3,702,532 99.92% 2,971 0.08% 1,562
ENDS
For more information, please contact:
Iconic Labs Tel: +44 (0) 7462 156238
John Farquharson
Chief Executive Officer
Novum Securities Limited Tel: +44 (0) 20 7399 9400
David Coffman / Daniel Harris
Yellow Jersey PR Tel: +44 (0) 20 3004 9512
Charles Goodwin iconic@yellowjerseypr.com
Annabelle Wills
Bessie Elliot
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RAGGPUQGAUPAGAA